Medication info
Hiaeol Tablets 10mg (Rosuvastatin Calcium)

Hiaeol Tablets 10mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets/PTP*2), 30 tablets/bottle, 90 tablets/bottle
Approval status
Active

MFDS item code 201000968 · Approved 2010.01.28 · Insurance code 653804410

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia: The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The dose may be increased to a maximum of 20 milligrams per day. Older adults: No dose adjustment is required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is used to manage hypercholesterolemia and hyperlipidemia. It is particularly effective as an adjunct to diet in patients with familial hypercholesterolemia, heterozygous familial hypercholesterolemia, combined hyperlipidemia, and dysbetalipoproteinemia. It also lowers total cholesterol and LDL-cholesterol levels, thereby delaying the progression of atherosclerosis and reducing the risk of cardiovascular diseases. It can be used in children aged 10 years and older for the management of hypercholesterolemia and helps in reducing the risks of stroke, myocardial infarction, and vascular intervention in high-risk patients with elevated high-sensitivity C-reactive protein levels. Overall, this medication is used to improve cardiovascular health and effectively regulate blood lipids.

How to take

Adult dose

Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia: The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The dose may be increased to a maximum of 20 milligrams per day. Older adults: No dose adjustment is required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used by certain patients. First, individuals who are allergic to any component of this medication should not take it. Patients with active liver disease or very high liver enzyme levels should also avoid this medication. Those with muscle disorders or severe renal impairment should not use it either. Caution is needed when using this medication in pregnant or lactating women and fertile women who do not use adequate contraception. Additionally, high dosages are contraindicated in patients at high risk for muscle disorders. This medication contains lactose and is not suitable for patients with lactose intolerance. Care should be taken when administering this medication to patients with a history of significant alcohol consumption or liver disease. Regular liver function tests should be performed, and this medication should be used only after treating any underlying conditions in patients with hypothyroidism or nephrotic syndrome. Muscle-related side effects such as myalgia, myopathy, or rhabdomyolysis can occur, so any symptoms should be reported to healthcare professionals immediately. Patients particularly at risk for muscle disorders should have muscle enzyme tests performed before and during treatment to monitor their condition. If severe muscle pain or weakness occurs, the medication should be stopped and a doctor consulted. This medication can affect liver function, so it should be stopped immediately if symptoms of liver damage appear. Blood sugar levels may rise, so patients at risk for diabetes should monitor their blood sugar periodically. This medication may interact with other drugs, so if there are any concomitant medications, it is essential to inform the healthcare provider. Particularly, the risk of muscle-related side effects can be increased when used with certain antivirals, immunosuppressants, antifungals, antibiotics, and fibrate class drugs. Additionally, there is a potential for interactions with antacids or certain anticoagulants, so caution is advised. During pregnancy or breastfeeding, this medication should be avoided due to potential harm to the fetus or infant. Women planning to become pregnant should use appropriate contraception and discontinue the medication immediately if pregnancy is confirmed. In the event of overdose, there is no specific antidote, so symptomatic treatment should be provided while monitoring liver function and muscle enzyme levels. Lastly, this medication can rarely cause severe skin reactions or interstitial lung disease, so healthcare professionals should be consulted immediately if skin rashes, breathing difficulties, or other unusual symptoms occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally between temperatures of 1 degree to 30 degrees Celsius. This will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/PTP*2), 30 tablets/bottle, 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.